Specific pathological reporting is necessary in patients going through neoadjuvant systemic therapy (NST). There exist no less than 5 various reporting scores for the grade of remission after NST; A few of these, nevertheless, are only validated for inflammatory breast most cancers (e. The recommendation is partially according to https://christiann429fmu5.wikigiogio.com/user